SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000200406-23-000073
Filing Date
2023-07-20
Accepted
2023-07-20 07:15:55
Documents
18
Period of Report
2023-07-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jnj-20230720.htm   iXBRL 8-K 37447
2 EX-99.1 a2023q2exhibit991.htm EX-99.1 60396
3 EX-99.2 a2023q2exhibit992.htm EX-99.2 1458837
8 overallresultsqtd.jpg GRAPHIC 24204
9 regionalsalesqtd.jpg GRAPHIC 13025
10 segmentsalesqtd.jpg GRAPHIC 17189
  Complete submission text file 0000200406-23-000073.txt   1888837

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnj-20230720.xsd EX-101.SCH 3333
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnj-20230720_def.xml EX-101.DEF 16758
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnj-20230720_lab.xml EX-101.LAB 34199
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnj-20230720_pre.xml EX-101.PRE 17560
12 EXTRACTED XBRL INSTANCE DOCUMENT jnj-20230720_htm.xml XML 6412
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

IRS No.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 231098072
SIC: 2834 Pharmaceutical Preparations